Quanterix has named Paul Chapman as its new president and CEO. In the latter role, Chapman replaces Martin Madaus who will remain as executive chairman of the privately held firm's board of directors.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.
Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.
Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.
Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.